What is Atomwise?
Founded in 2012 and based in California, Atomwise Inc. leverages artificial intelligence to revolutionize drug discovery. The company's proprietary AI platform is designed to predict how small molecules will behave and interact, significantly speeding up the identification of potential drug candidates. This technology aims to reduce the time and cost associated with traditional drug development pipelines, offering a powerful tool for pharmaceutical and biotechnology companies seeking to bring new therapies to market more efficiently. Atomwise's focus on AI in this critical sector positions it at the forefront of a transformative shift in medical research.
How much funding has Atomwise raised?
Atomwise has raised a total of $221.6M across 7 funding rounds:
Unspecified
$225K
Other Financing Round
$120K
Angel/Seed
$6M
Series A
$45M
Series B
$123M
Grant
$2.3M
Series C
$45M
Unspecified (2013): $225K with participation from Grand Challenges Canada
Other Financing Round (2015): $120K led by Y Combinator and David E. Weekly
Angel/Seed (2015): $6M supported by Khosla Ventures, Draper Fisher Jurvetson, AME Cloud Ventures, Data Collective, and OS Fund
Series A (2018): $45M featuring Baidu Ventures, Tencent, B Capital Group, Monsanto Growth Ventures, Khosla Ventures, Data Collective, and Y Combinator
Series B (2020): $123M backed by Dolby Family Ventures, AME Cloud Ventures, B Capital Group, Tencent, Sanabil Investments, Y Combinator, DCVC, and BV
Grant (2020): $2.3M with participation from Bill & Melinda Gates Foundation
Series C (2024): $45M led by B Capital Group and Khosla Ventures
Key Investors in Atomwise
B Capital Group
B Capital is a venture capital firm focused on early and late-stage companies in Technology, Healthcare, and Climate sectors, aiming to empower entrepreneurs with significant assets under management and a global presence.
Khosla Ventures
Khosla Ventures provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies, with a broad investment focus including AI, fintech, health, and sustainable energy.
Tencent
Tencent Holdings Limited is a global internet and mobile services provider, offering online games, applications, and various digital services, headquartered in Shenzhen, China.
What's next for Atomwise?
With the infusion of major enterprise-level funding and a recent strategic investment, Atomwise is poised for accelerated growth and expansion. This capital injection is expected to fuel further development of its AI platform, enhance its research capabilities, and potentially broaden its partnerships within the pharmaceutical industry. The company's trajectory suggests a move towards scaling its operations and solidifying its position as a leader in AI-driven drug discovery, aiming to translate its technological advancements into tangible therapeutic breakthroughs.
See full Atomwise company page
